Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 13 Neoplasms, Plasma Cell 3 Recurrence 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma of Lung 2 Waldenstrom Macroglobulinemia 1 Sarcoma 1 Renal Insufficiency 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Polyneuropathies 1 Paraproteinemias 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Endocrine System Diseases 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Biopsy 4 Surgical Procedures, Operative 3 Cisplatin 3 Cetuximab 3 Radiotherapy 2 Fluorouracil 2 Cyclophosphamide 2 Celecoxib 2 tozuleristide 1 temsirolimus 1 antineoplaston AS 2-1 1 antineoplaston A10 1 advexin 1 Valproic Acid 1 Thalidomide 1 Sirolimus 1 Observation 1 Metformin 1 Immunohistochemistry 1 Immunoglobulin G 1 Fluorescent Antibody Technique 1 Flow Cytometry 1 Fenretinide 1 Everolimus 1 Etoposide 1 Electroacupuncture 1 Docetaxel 1 Disulfides 1 Dihematoporphyrin Ether 1 Diagnosis, Oral 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Mouth Neoplasms × Thalidomide × Clear all

NCT00934739 2015-02-25

A Study of High-Risk Oral Cavity Cancer

National Health Research Institutes, Taiwan

Phase 2/3 Terminated

Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡